HULC (highly upregulated in liver cancer) is known to reduce the expression of protein kinase cAMP-activated catalytic subunit beta (PRKACB) and to increase the HMGA2 oncogene via interaction with miR-372 and miR-186 in HCC [116,117]. The gene discussed is HMGA2; the disease is hepatocellular carcinoma.